Drug Shortage Report for SODIUM BICARBONATE INJECTION USP

Last updated on 2025-12-03 History
Report ID 264085
Drug Identification Number 02541904
Brand name SODIUM BICARBONATE INJECTION USP
Common or Proper name SODIUM BICARBONATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 84MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2025-08-01
Estimated end date 2025-11-28
Actual end date 2025-12-01
Shortage status Resolved
Updated date 2025-12-03
Company comments Product is available and is on 100% preventative allocation at McKesson.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-12-03 French Compare
v8 2025-12-03 English Compare
v7 2025-10-16 French Compare
v6 2025-10-16 English Compare
v5 2025-10-01 French Compare
v4 2025-10-01 English Compare
v3 2025-08-02 English Compare
v2 2025-08-01 French Compare
v1 2025-08-01 English Compare

Showing 1 to 9 of 9